118.73 USD
-4.24
3.45%
At close Aug 25, 4:00 PM EDT
1 day
-3.45%
5 days
-1.68%
1 month
-6.67%
3 months
-3.72%
6 months
-19.91%
Year to date
-21.33%
1 year
-34.96%
5 years
9.76%
10 years
693.12%
 

About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Employees: 3,000

0
Funds holding %
of 7,429 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

32% more repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 100

5% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 43

0% less capital invested

Capital invested by funds: $4.52B [Q1] → $4.51B (-$5.67M) [Q2]

1.01% less ownership

Funds ownership: 98.22% [Q1] → 97.22% (-1.01%) [Q2]

2% less funds holding

Funds holding: 321 [Q1] → 316 (-5) [Q2]

85% less call options, than puts

Call options by funds: $247K | Put options by funds: $1.7M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$133
12%
upside
Avg. target
$133
12%
upside
High target
$133
12%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Baird
Robert Mason
12%upside
$133
Neutral
Maintained
11 Aug 2025

Financial journalist opinion

Based on 5 articles about NOVT published over the past 30 days

Neutral
Business Wire
1 week ago
Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life.
Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025
Neutral
The Motley Fool
2 weeks ago
Novanta (NOVT) Q2 Revenue Rises 2.2%
Novanta (NOVT) Q2 Revenue Rises 2.2%
Novanta (NOVT) Q2 Revenue Rises 2.2%
Neutral
Seeking Alpha
2 weeks ago
Novanta Inc. (NOVT) Q2 2025 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT ) Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ET Company Participants Matthijs Glastra - CEO & Chairman of the Board Ray Nash - Corporate Participant Corporate Finance Leader & IR - Corporate Participant Robert J. Buckley - Chief Financial Officer Conference Call Participants Brian Paul Drab - William Blair & Company L.L.C.
Novanta Inc. (NOVT) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
2 weeks ago
Novanta (NOVT) Q2 Earnings and Revenues Top Estimates
Novanta (NOVT) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.73 per share a year ago.
Novanta (NOVT) Q2 Earnings and Revenues Top Estimates
Neutral
Business Wire
3 weeks ago
Novanta Announces Financial Results for the Second Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amounts) June 27,     June 28,     2025     2024   GAAP           Revenue $ 241.0     $ 235.9   Operating Income $ 14.9     $ 25.7   Net Income $ 4.5     $ 13.8   Diluted EPS $ 0.12     $ 0.38.
Novanta Announces Financial Results for the Second Quarter 2025
Neutral
Business Wire
1 month ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 results on Tuesday, August 5, 2025. The Company will host a conference call on Tuesday, August 5, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a li.
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
Neutral
Business Wire
2 months ago
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025, in White Plains, New York. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial.
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
Neutral
Business Wire
3 months ago
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial orig.
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
Neutral
Business Wire
3 months ago
Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, in Chicago, IL. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial origi.
Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025
Neutral
Seeking Alpha
3 months ago
Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT ) Q1 2025 Results Conference Call May 6, 2025 10:00 AM ET Company Participants Ray Nash - Investor Relations Matthijs Glastra - Chair & Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Rob Mason - Baird Operator Good morning. My name is Gary, and I will be your conference operator today.
Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript
Charts implemented using Lightweight Charts™